title: FOXA1 mutations in hormone-dependent cancers.
abstract: The forkhead protein, FOXA1, is a critical interacting partner of the nuclear hormone receptors, oestrogen receptor-α (ER) and androgen receptor (AR), which are major drivers of the two most common cancers, namely breast and prostate cancer. Over the past few years, progress has been made in our understanding of how FOXA1 influences nuclear receptor function, with both common and distinct roles in the regulation of ER or AR. Recently, another level of regulation has been described, with the discovery that FOXA1 is mutated in 1.8% of breast and 3-5% prostate cancers. In addition, a subset of both cancer types exhibit amplification of the genomic region encompassing the FOXA1 gene. Furthermore, there is evidence of somatic changes that influence the DNA sequence under FOXA1 binding regions, which may indirectly influence FOXA1-mediated regulation of ER and AR activity. These recent observations provide insight into the heterogeneity observed in ER and AR driven cancers.
authors: Cancer Research UK, Robinson Way Cambridge, UK ; Department of Oncology, University of Cambridge Cambridge, UK.
authors: Jessica L L
authors: JL
authors: Robinson
authors: Kelly A
authors: KA
authors: Holmes
authors: Jason S
authors: JS
authors: Carroll
keywords: FoxA1; SNP; androgen receptor (AR); breast cancer; estrogen receptor alpha; exome sequencing; prostate cancer